bempegaldesleukin
17-214-09
Phase 3 mab terminated
Quick answer
bempegaldesleukin for Renal Cell Carcinoma is a Phase 3 program (mab) at NEKTAR THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NEKTAR THERAPEUTICS
- Indication
- Renal Cell Carcinoma
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated